申请人:DeGoey David A.
公开号:US20110207699A1
公开(公告)日:2011-08-25
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
本发明描述了有效抑制丙型肝炎病毒(“HCV”)复制的化合物。本发明还涉及制造这种化合物的过程、包含这种化合物的组合物以及使用这种化合物治疗HCV感染的方法。